Physician profile
Timothy J Burrell
NPI 1457672289
$402.13
in general payments reported to CMS, 2019-2025
14 companies · $49.27 in 2025
The $49.27 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.09 · 2020: $13.75 · 2021: $64.00 · 2022: $131 · 2023: $102 · 2024: $28.07 · 2025: $49.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $75.07 | 2021-2023 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $49.84 | 2019-2023 | |
| Abbvie INC. | $42.68 | 2022-2025 | |
| Glaxosmithkline, LLC. | $40.42 | 2020-2024 | Shingrix |
| E.R. Squibb & Sons, L.L.C. | $36.59 | 2022-2023 | Eliquis |
| Amgen INC. | $26.15 | 2021-2023 | Repatha, Otezla |
| Lilly USA, LLC | $25.01 | 2021-2022 | |
| Inspire Medical Systems, INC. | $17.83 | 2025 | Inspire |
| Astellas Pharma US INC | $16.63 | 2022 | |
| Currax Pharmaceuticals LLC | $15.36 | 2025 | Contrave |
| Abbott Laboratories | $14.96 | 2021 | |
| Exact Sciences Corporation | $14.94 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $14.71 | 2022 | |
| Pfizer INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Burrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.